Olaf Rose
Impact in
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
- Family Practice top 10%
- Medication Adherence and Compliance
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 14
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Pharmaceutical Economics and Policy 3
- Co-authors
- Juliane Köberlein–Neu (8 shared papers)Ulrich Jaehde (5 shared papers)Stefanie Hamacher (4 shared papers)Anna Starzinski‐Powitz (1 shared paper)Jürgen Rohwedel (1 shared paper)Michael Bachmann (1 shared paper)Matthias Cramer (1 shared paper)Anna M. Wobus (1 shared paper)
- Journals
- International Journal of Clinical Pharmacy (4 papers)BMJ Open (2 papers)Research in Social and Administrative Pharmacy (2 papers)Biomedicines (1 paper)Age and Ageing (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Olaf Rose
33 papers receiving 382 citations
Peers
Comparison fields: 5 of 70
- Geriatrics and Gerontology 143
- Family Practice 21
- Applied Microbiology and Biotechnology 6
- Toxicology 11
- Aging 4
Countries citing papers authored by Olaf Rose
This map shows the geographic impact of Olaf Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Rose more than expected).
Fields of papers citing papers by Olaf Rose
This network shows the impact of papers produced by Olaf Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Rose. The network helps show where Olaf Rose may publish in the future.
Co-authors
The 25 scholars most cited alongside Olaf Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 87 | |
| 2 | 2016 | 56 | |
| 3 | 2016 | 36 | |
| 4 | 2020 | 28 | |
| 5 | 2018 | 23 | |
| 6 | 2015 | 22 | |
| 7 | 2020 | 18 | |
| 8 | 2017 | 17 | |
| 9 | 2018 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2017 | 8 | |
| 12 | 2020 | 8 | |
| 13 | 2018 | 8 | |
| 14 | 2018 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2024 | 5 | |
| 17 | Parkinson’s Disease: Basic knowledge. | 2016 | 5 |
| 18 | 2021 | 4 | |
| 19 | 2020 | 4 | |
| 20 | 2020 | 4 |
About Olaf Rose
Olaf Rose is a scholar working on Geriatrics and Gerontology, Economics and Econometrics, Neurology, Pediatrics, Perinatology and Child Health and Family Practice, having authored 36 papers that have together received 389 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (14 papers), Medication Adherence and Compliance (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Pharmaceutical studies and practices (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Pharmaceutical Economics and Policy (3 papers), Neurological disorders and treatments (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Geriatrics and Gerontology (143 citations), Family Practice (21 citations), Applied Microbiology and Biotechnology (6 citations), Toxicology (11 citations) and Aging (4 citations). Olaf Rose has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Juliane Köberlein–Neu, Ulrich Jaehde, Stefanie Hamacher, Anna Starzinski‐Powitz, Jürgen Rohwedel, Michael Bachmann, Matthias Cramer, Anna M. Wobus, Sigrid Reinhardt and Moritz Felsch. Their work appears in journals such as International Journal of Clinical Pharmacy, BMJ Open, Research in Social and Administrative Pharmacy, Biomedicines and Age and Ageing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.